Salix To Buy Santarus For $2.6 Billion For Diabetes Drug

Posted on

Santarus sells Glumetza for Type 2 diabetes , which analysts estimate will generate $221.6 million in 2015 revenue, and Zegerid for heartburn, forecast for $106.3 million in sales. The deal is transformative for Salix both commercially and financially, fulfilling many of our strategic needs while providing immediate and significant accretion in 2014 and beyond, Logan said in the statement. The companies said they expect the acquisition to close in the first quarter of 2014. There have been 44 acquisitions of specialty drug companies for more than $500 million in the last three years, according to data compiled by Bloomberg. The average disclosed size was $1.2 billion and average premium was 20 percent, the data show. The largest deal was Perrigo Co.
For the original version including any supplementary images or video, visit

New drugs for diabetes types I & II

Five of the new drugs are for diabetes type II and the remaining drug addresses type I diabetes Japanese pharmaceutical company Takeda Pharmaceutical CL and its American sister company Takeda Pharmaceuticals U.S.A. Inc. recently received approval for three new types II diabetes drugs: Nesina (alogliptin), Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCI). Research is backed by world-wide clinical trials with over 13,000 participants. SEE RELATED: Hepatitis C will be eradicated starting in weeks Nesina (alogliptin) works by increasing the active incretins enabling the pancreas to secrete insulin in a glucose dependent manner. Oseni combines alogliptin andpioglitazoneto control blood glucose levels.
For the original version including any supplementary images or video, visit

Diabetes Google Doodle

Diabetes Google Doodle

Thats why, after decades with the disease, most of us are still baffled. Of course, to know this, youd have to have diabetes yourself, or be close to someone with it which circles us back to the original issue: raising diabetes awareness. I figured that if Google didnt want to make a diabetes doodle, maybe I could. I began my doodle last year, but I never finished it.
For the original version including any supplementary images or video, visit

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s